229 related articles for article (PubMed ID: 11241176)
1. Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate.
Royuela M; de Miguel MP; Bethencourt FR; Sánchez-Chapado M; Fraile B; Arenas MI; Paniagua R
J Endocrinol; 2001 Mar; 168(3):447-54. PubMed ID: 11241176
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.
Leav I; Lau KM; Adams JY; McNeal JE; Taplin ME; Wang J; Singh H; Ho SM
Am J Pathol; 2001 Jul; 159(1):79-92. PubMed ID: 11438457
[TBL] [Abstract][Full Text] [Related]
4. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features.
Gabal SM; Habib FM; Helmy DO; Ibrahim MF
J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia.
Schulze H; Barrack ER
Prostate; 1987; 11(2):145-62. PubMed ID: 2444954
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia.
Gangkak G; Bhattar R; Mittal A; Yadav SS; Tomar V; Yadav A; Mehta J
Investig Clin Urol; 2017 Mar; 58(2):117-126. PubMed ID: 28261681
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue.
Brolin J; Skoog L; Ekman P
Prostate; 1992; 20(4):281-95. PubMed ID: 1376911
[TBL] [Abstract][Full Text] [Related]
11. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry.
Schulze H; Claus S
Prostate; 1990; 16(4):331-43. PubMed ID: 1695369
[TBL] [Abstract][Full Text] [Related]
12. Immunoexpressions of p21, Rb, mcl-1 and bad gene products in normal, hyperplastic and carcinomatous human prostates.
Royuela M; Arenas MI; Bethencourt FR; Sánchez-Chapado M; Fraile B; Paniagua R
Eur Cytokine Netw; 2001; 12(4):654-63. PubMed ID: 11781193
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptors in the human male prostatic urethra and prostate in prostatic cancer and benign prostatic hyperplasia.
Bødker A; Bruun J; Balslev E; Iversen HG; Meyhoff HH; Andersson KE
Scand J Urol Nephrol; 1999 Aug; 33(4):237-42. PubMed ID: 10515086
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
[TBL] [Abstract][Full Text] [Related]
15. E-, N- and P-cadherin, and alpha-, beta- and gamma-catenin protein expression in normal, hyperplastic and carcinomatous human prostate.
Arenas MI; Romo E; Royuela M; Fraile B; Paniagua R
Histochem J; 2000 Nov; 32(11):659-67. PubMed ID: 11272805
[TBL] [Abstract][Full Text] [Related]
16. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
[TBL] [Abstract][Full Text] [Related]
18. The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions.
Levakov AF; Kaćanski MM; Vucković N; Zivojinov M; Amidzić J; Sabo JI
Vojnosanit Pregl; 2015 Oct; 72(10):906-13. PubMed ID: 26665557
[TBL] [Abstract][Full Text] [Related]
19. IL-2, its receptors, and bcl-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: immunohistochemical comparative analysis.
Royuela M; De Miguel MP; Bethencourt FR; Fraile B; Arenas MI; Paniagua R
Growth Factors; 2000; 18(2):135-46. PubMed ID: 11019784
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of estrogen receptor-beta expression in prostate cancer.
Horvath LG; Henshall SM; Lee CS; Head DR; Quinn DI; Makela S; Delprado W; Golovsky D; Brenner PC; O'Neill G; Kooner R; Stricker PD; Grygiel JJ; Gustafsson JA; Sutherland RL
Cancer Res; 2001 Jul; 61(14):5331-5. PubMed ID: 11454669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
